This report, part of the Access Denied series, explores the role that UK public entities have played in supporting the development of COVID-19 tools such as diagnostics, vaccines and treatments. It highlights how the lack of equitable access safeguards across the research and development (R&D) continuum results in the perpetuation of an extractive global health … Continued
Three years on, the COVID-19 pandemic has officially caused the deaths of over 7 million people, disrupting livelihoods globally and continuing to have a devastating impact on communities that don’t have widespread access to health technologies. The world’s response to the pandemic has demonstrated the flaws in the existing global system for the research, development … Continued
STOPAIDS and Global Health Advocates’ report series ‘Access Denied‘ explores how a lack of transparency in the pharmaceutical industry and the EU has harmed public health outcomes. The series is structured into two reports. The first set the scene through speaking to key actors and stakeholders who were involved in or following the contract negotiations. In … Continued
From Public-Private Partnerships to biomedical Research & Development funding, there has been a substantial increase in the amount of development finance being channeled to the private sector to support the delivery of global development goals. Whilst there are examples of private sector engagement which has advanced global health outcomes, responding to the risks associated with … Continued
STOPAIDS and other organisations have produced a briefing asking the UK to step up it’s leadership to end epidemics through investing in the Global Fund To Fight AIDS, TB and Malaria. The target for the Global Fund’s Seventh Replenishment is to raise at least US$18 billion to get the world back on track toward ending HIV, TB … Continued
Since the creation of the Global Fund to Fight AIDS, TB and Malaria (Global Fund) in 2002, nearly 20 years ago, the UK has been a leading donor and partner. In this time the Global Fund has showcased what is possible when governments, civil society and private sector stakeholders come together to achieve progress. … Continued
https://stopaids.org.uk/wp-content/uploads/2020/04/Equitable-access-to-COVID-19-diagnostics-vaccines-and-treatments-1-1.pdf
The Factsheet explores how STOPAIDS members, allies and partners are leading by example in their efforts to couple the advancement of the HIV response with the achievement of UHC. It identifies six key thematic building blocks of the HIV response which we believe will also underpin UHC. Within these we analyse the lessons from the … Continued
Girls and young women aged 15-24 years in sub-Saharan Africa are up to eight times more likely to be HIV positive compared to boys and men of the same age. This age group is expected to double in sub-Saharan Africa in the next decade and therefore urgent action is needed to end the epidemic and prevent a resurgence of HIV. In stepping up its work against gender-based health inequalities, the Global Fund has more than quadrupled investments to reduce new HIV infections for adolescent girls and young women in sub-Saharan Africa with strong community-based prevention programmes. The Global Fund has also recently set a bold target to reduce the number of new HIV infections among adolescent girls and young women by 58% in 13 African countries over the next five years as part of their HER: HIV Epidemic Response campaign.
This paper explains the interconnections between certain Sustainable Development Goal targets, human rights laws, and HIV. Ending AIDS is now part of a broader health goal within the Sustainable Development Goals (SDGs). Those who are committed to ending the AIDS epidemic realise that a purely medical response is not effective. The AIDS response must also … Continued